Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18940 | 529 | 42.5 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
298 | 3 | UROLOGY & NEPHROLOGY//PROTEINURIA//NEPHROTIC SYNDROME | 41270 |
572 | 2 | PODOCYTE//NEPHRIN//KIDNEY INTERNATIONAL | 14360 |
18940 | 1 | HEMODYNAMIC MALADJUSTMENT//GLOMERULAR ENDOTHELIAL DYSFUNCTION//MOL PATHOL IMMUNOL CORE | 529 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HEMODYNAMIC MALADJUSTMENT | authKW | 404052 | 1% | 100% | 7 |
2 | GLOMERULAR ENDOTHELIAL DYSFUNCTION | authKW | 288608 | 1% | 100% | 5 |
3 | MOL PATHOL IMMUNOL CORE | address | 240505 | 1% | 83% | 5 |
4 | RENAL MICROVASCULAR DISEASE | authKW | 240505 | 1% | 83% | 5 |
5 | FE MG | authKW | 235691 | 1% | 58% | 7 |
6 | PERITUBULAR CAPILLARY FLOW | authKW | 230887 | 1% | 100% | 4 |
7 | ENDOTHELIAL CELL CYTOTOXICITY | authKW | 173165 | 1% | 100% | 3 |
8 | ENHANCED RENAL PERFUSION | authKW | 115443 | 0% | 100% | 2 |
9 | FEMG | authKW | 76961 | 0% | 67% | 2 |
10 | FRACTIONAL EXCRETION OF MAGNESIUM | authKW | 76961 | 0% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Urology & Nephrology | 16473 | 51% | 0% | 271 |
2 | Transplantation | 606 | 7% | 0% | 39 |
3 | Endocrinology & Metabolism | 422 | 12% | 0% | 63 |
4 | Physiology | 360 | 10% | 0% | 52 |
5 | Peripheral Vascular Diseases | 308 | 8% | 0% | 41 |
6 | Pathology | 253 | 7% | 0% | 36 |
7 | Medicine, Research & Experimental | 210 | 9% | 0% | 45 |
8 | Hematology | 38 | 3% | 0% | 18 |
9 | Cell Biology | 20 | 5% | 0% | 28 |
10 | Immunology | 17 | 5% | 0% | 25 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL PATHOL IMMUNOL CORE | 240505 | 1% | 83% | 5 |
2 | MANCHESTER RENAL GRP | 76961 | 0% | 67% | 2 |
3 | CENAIA | 57722 | 0% | 100% | 1 |
4 | DEV TECHNOL SCI | 57722 | 0% | 100% | 1 |
5 | DIABET ENDOCRINOL INTERNAL MED MED | 57722 | 0% | 100% | 1 |
6 | DORRAM HAMILTON S | 57722 | 0% | 100% | 1 |
7 | DORRANCE HAMILTON | 57722 | 0% | 100% | 1 |
8 | ENDOCRINOL DIABETMETAB MED UNIT | 57722 | 0% | 100% | 1 |
9 | ICSM HAMMERSMITH HOSP | 57722 | 0% | 100% | 1 |
10 | IPNH | 57722 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RENAL FAILURE | 16489 | 6% | 1% | 32 |
2 | JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 14701 | 8% | 1% | 43 |
3 | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | 11388 | 7% | 1% | 36 |
4 | KIDNEY INTERNATIONAL | 6668 | 8% | 0% | 41 |
5 | NEPHRON EXPERIMENTAL NEPHROLOGY | 5620 | 1% | 1% | 7 |
6 | CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION | 3622 | 2% | 1% | 10 |
7 | NEPHRON PHYSIOLOGY | 2913 | 1% | 2% | 3 |
8 | CLINICAL HEMORHEOLOGY AND MICROCIRCULATION | 2567 | 2% | 0% | 9 |
9 | NEPHROLOGY DIALYSIS TRANSPLANTATION | 2443 | 4% | 0% | 23 |
10 | ASIAN BIOMEDICINE | 1595 | 1% | 1% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SCHRIJVERS, BF , FLYVBJERG, A , DE VRIESE, AS , (2004) THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN RENAL PATHOPHYSIOLOGY.KIDNEY INTERNATIONAL. VOL. 65. ISSUE 6. P. 2003-2017 | 56 | 47% | 238 |
2 | CHEN, S , ZIYADEH, FN , (2008) VASCULAR ENDOTHELIAL GROWTH FACTOR AND DIABETIC NEPHROPATHY.CURRENT DIABETES REPORTS. VOL. 8. ISSUE 6. P. 470-476 | 31 | 66% | 31 |
3 | ADVANI, A , (2014) VASCULAR ENDOTHELIAL GROWTH FACTOR AND THE KIDNEY: SOMETHING OF THE MARVELLOUS.CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. VOL. 23. ISSUE 1. P. 87-92 | 27 | 57% | 3 |
4 | MIRONIDOU-TZOUVELEKI, M , TSARTSALIS, S , TOMOS, C , (2011) VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN THE PATHOGENESIS OF DIABETIC NEPHROPATHY OF TYPE 1 DIABETES MELLITUS.CURRENT DRUG TARGETS. VOL. 12. ISSUE 1. P. 107-114 | 43 | 37% | 15 |
5 | NAKAGAWA, T , KOSUGI, T , HANEDA, M , RIVARD, CJ , LONG, DA , (2009) ABNORMAL ANGIOGENESIS IN DIABETIC NEPHROPATHY.DIABETES. VOL. 58. ISSUE 7. P. 1471-1478 | 31 | 44% | 66 |
6 | FUTRAKUL, N , CHANAKUL, A , FUTRAKUL, P , DEEKAJORNDECH, T , (2015) EARLY STAGE OF VASCULAR DISEASE AND DIABETIC KIDNEY DISEASE: AN UNDER-RECOGNIZED ENTITY.RENAL FAILURE. VOL. 37. ISSUE 8. P. 1243 -1246 | 19 | 70% | 0 |
7 | KIM, HW , LIM, JH , KIM, MY , CHUNG, S , SHIN, SJ , CHUNG, HW , CHOI, BS , KIM, YS , CHANG, YS , PARK, CW , (2011) LONG-TERM BLOCKADE OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 AGGRAVATES THE DIABETIC RENAL DYSFUNCTION ASSOCIATED WITH INACTIVATION OF THE AKT/ENOS-NO AXIS.NEPHROLOGY DIALYSIS TRANSPLANTATION. VOL. 26. ISSUE 4. P. 1173 -1188 | 25 | 54% | 12 |
8 | NAKAGAWA, T , (2009) A NEW MOUSE MODEL RESEMBLING HUMAN DIABETIC NEPHROPATHY. UNCOUPLING OF VEGF WITH ENOS AS A NOVEL PATHOGENIC MECHANISM.CLINICAL NEPHROLOGY. VOL. 71. ISSUE 2. P. 103-109 | 22 | 65% | 16 |
9 | LOGUE, OC , MCGOWAN, JWD , GEORGE, EM , BIDWELL, GL , (2016) THERAPEUTIC ANGIOGENESIS BY VASCULAR ENDOTHELIAL GROWTH FACTOR SUPPLEMENTATION FOR TREATMENT OF RENAL DISEASE.CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. VOL. 25. ISSUE 5. P. 404 -409 | 26 | 44% | 1 |
10 | DEEKAJORNDECH, T , (2007) A BIOMARKER FOR DETECTING EARLY TUBULOINTERSTITIAL DISEASE AND ISCHEMIA IN GLOMERULONEPHROPATHY.RENAL FAILURE. VOL. 29. ISSUE 8. P. 1013-1017 | 15 | 100% | 7 |
Classes with closest relation at Level 1 |